Stifel analyst Alex Thompson initiates coverage on Third Harmonic Bio (NASDAQ:THRD) with a Buy rating and announces Price Target of $23.
- Headlines
- Stifel Initiates Coverage On Third Harmonic Bio With Buy Rating, Announces Price Target of $23
Stifel Initiates Coverage On Third Harmonic Bio With Buy Rating, Announces Price Target of $23
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
09:05
Citibank: Lowered Tencent's total revenue growth forecast for the fourth quarter of 2024
C+1.92%
09:01
The FTSE Singapore Straits Index fell by approximately 0.1%, HongkongLand USD dropped by over 1%, JMH USD, DFIRG USD, DBS Group Holdings, Singtel, and others experienced slight declines.
FTSE Singapore Straits Time Index-0.09%
09:00
FTSE China A50 Index Futures opened up 0.06%.
FTSE China A50 Index-0.29%